Compare RKT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RKT | TEVA |
|---|---|---|
| Founded | 1985 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 40.5B |
| IPO Year | 2020 | 1996 |
| Metric | RKT | TEVA |
|---|---|---|
| Price | $12.11 | $38.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 8 |
| Target Price | $20.40 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 26.8M | 4.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $66.40 | N/A |
| Revenue Next Year | $8.18 | $2.97 |
| P/E Ratio | $63.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.11 | $18.27 |
| 52 Week High | $24.36 | $40.79 |
| Indicator | RKT | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 58.07 |
| Support Level | N/A | $30.42 |
| Resistance Level | $14.61 | N/A |
| Average True Range (ATR) | 0.48 | 1.15 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 2.86 | 63.69 |
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.